The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-08-22
DOI
10.1002/hep.32740
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma
- (2022) Andrew X. Zhu et al. NATURE MEDICINE
- IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC).
- (2021) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic Efficacy of Dendritic Cell Vaccine Combined with Programmed Death 1 Inhibitor for Hepatocellular Carcinoma
- (2021) Chiao‐Fang Teng et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma
- (2021) Jason Behary et al. Nature Communications
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer‐associated fibroblast‐mediated cellular crosstalk supports hepatocellular carcinoma progression
- (2021) Mengjia Song et al. HEPATOLOGY
- Radiotherapy as an immune checkpoint blockade combination strategy for hepatocellular carcinoma
- (2021) Byung Min Lee et al. WORLD JOURNAL OF GASTROENTEROLOGY
- NASH limits anti-tumour surveillance in immunotherapy-treated HCC
- (2021) Dominik Pfister et al. NATURE
- Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH
- (2021) Michael Dudek et al. NATURE
- Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study
- (2021) Shukui Qin et al. Liver Cancer
- Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy
- (2021) Valentina Cazzetta et al. Cancers
- The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic Target
- (2021) Xiangqian Guan et al. Journal of Hepatocellular Carcinoma
- Pilot study to determine the safety and feasibility of deceased donor liver natural killer cell infusion to liver transplant recipients with hepatocellular carcinoma
- (2021) Masahiro Ohira et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002–2020)
- (2021) Philipp K. Haber et al. GASTROENTEROLOGY
- Regulatory T cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis
- (2021) Han Wang et al. JOURNAL OF HEPATOLOGY
- Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma
- (2021) Haijing Deng et al. Journal for ImmunoTherapy of Cancer
- Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
- (2021) Konstantinos Arvanitakis et al. Cancers
- Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma
- (2021) Annabelle Vogt et al. Cancers
- Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
- (2021) Hee Ho Chu et al. Cancers
- The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
- (2021) Ester Gonzalez-Sanchez et al. Cancers
- Natural Killer Cells and T Cells in Hepatocellular Carcinoma and Viral Hepatitis: Current Status and Perspectives for Future Immunotherapeutic Approaches
- (2021) Suresh Gopi Kalathil et al. Cells
- Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma
- (2021) Miaomiao Qin et al. Frontiers in Oncology
- Increased neutrophil extracellular traps promote metastasis potential of hepatocellular carcinoma via provoking tumorous inflammatory response
- (2020) Lu-Yu Yang et al. Journal of Hematology & Oncology
- Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
- (2020) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Gut microbiome in HCC – Mechanisms, diagnosis and therapy
- (2020) Robert F. Schwabe et al. JOURNAL OF HEPATOLOGY
- Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials
- (2020) Frits van Rhee et al. Lancet Haematology
- Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma
- (2020) Alessandra Zecca et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase 1 Trials
- (2020) Donghua Shi et al. CLINICAL CANCER RESEARCH
- Glycolytic activation of monocytes regulates the accumulation and function of neutrophils in human hepatocellular carcinoma
- (2020) Zhi-Peng Peng et al. JOURNAL OF HEPATOLOGY
- Ectosomal PKM2 Promotes HCC by Inducing Macrophage Differentiation and Remodeling the Tumor Microenvironment
- (2020) Pei-pei Hou et al. MOLECULAR CELL
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural Killer Cell Responses in Hepatocellular Carcinoma: Implications for Novel Immunotherapeutic Approaches
- (2020) Stefania Mantovani et al. Cancers
- Safety and Long-Term Outcome of Intratumoral Injection of OK432-Stimulated Dendritic Cells for Hepatocellular Carcinomas After Radiofrequency Ablation
- (2020) Masaaki Kitahara et al. Translational Oncology
- Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
- (2020) Hidetaka Yasuoka et al. Scientific Reports
- Targeting NK Cell Checkpoint Receptors or Molecules for Cancer Immunotherapy
- (2020) Cai Zhang et al. Frontiers in Immunology
- IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma
- (2020) Wenjie Zhang et al. Journal for ImmunoTherapy of Cancer
- Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma
- (2020) Katharina Leuchte et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma
- (2020) Ankur Sharma et al. CELL
- Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
- (2020) Dexi Zhou et al. Gut and Liver
- Dendritic Cell and T Cell Crosstalk in Liver Fibrogenesis and Hepatocarcinogenesis: Implications for Prevention and Therapy of Liver Cancer
- (2020) Isabella Lurje et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression
- (2020) Akira Asai et al. Cancers
- Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma
- (2020) Yunfan Sun et al. CELL
- A single cell atlas of the human liver tumor microenvironment
- (2020) Hassan Massalha et al. Molecular Systems Biology
- One Single Site Clinical Study: To Evaluate the Safety and Efficacy of Immunotherapy With Autologous Dendritic Cells, Cytokine-Induced Killer Cells in Primary Hepatocellular Carcinoma Patients
- (2020) Kaiyue Xu et al. Frontiers in Oncology
- WNT/β-catenin pathway activation correlates with immune exclusion across human cancers
- (2019) Jason J. Luke et al. CLINICAL CANCER RESEARCH
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression
- (2019) Dengke Bao et al. ONCOGENE
- Adoptive Transfer of NKG2D CAR mRNA-Engineered Natural Killer Cells in Colorectal Cancer Patients
- (2019) Lin Xiao et al. MOLECULAR THERAPY
- Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade
- (2019) Ying Zhu et al. GUT
- Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
- (2019) Xiu-Tao Fu et al. Cancer Cell International
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- The Intersection between Tumor Angiogenesis and Immune Suppression
- (2019) Osama E. Rahma et al. CLINICAL CANCER RESEARCH
- Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma
- (2019) Man Liu et al. GUT
- Sorafenib Induces Pyroptosis in Macrophages and Triggers Natural Killer Cell–Mediated Cytotoxicity Against Hepatocellular Carcinoma
- (2019) Carina Hage et al. HEPATOLOGY
- A Positive Feedback Loop Between Cancer Stem‐Like Cells and Tumor‐Associated Neutrophils Controls Hepatocellular Carcinoma Progression
- (2019) Shao‐Lai Zhou et al. HEPATOLOGY
- Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.
- (2019) Thomas Yau et al. JOURNAL OF CLINICAL ONCOLOGY
- Glycolytic Activation of Peritumoral Monocytes Fosters Immune Privilege via PFKFB3-PD-L1 axis in Human Hepatocellular Carcinoma
- (2019) Dong-Ping Chen et al. JOURNAL OF HEPATOLOGY
- Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer
- (2019) Mohsen Malehmir et al. NATURE MEDICINE
- Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resection
- (2019) Zheng-Jun Zhou et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
- (2019) Jing Cao et al. WORLD JOURNAL OF GASTROENTEROLOGY
- β-Catenin Activation Promotes Immune Escape and Resistance to Anti–PD-1 Therapy in Hepatocellular Carcinoma
- (2019) Marina Ruiz de Galarreta et al. Cancer Discovery
- Platelets as Key Factors in Hepatocellular Carcinoma
- (2019) Natasa Pavlovic et al. Cancers
- Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells
- (2019) Charles-Antoine Dutertre et al. IMMUNITY
- Eradication of Hepatocellular Carcinoma by NKG2D-Specific CAR-T Cells
- (2019) Bin Sun et al. Cancer Immunology Research
- Chimeric antigen receptor modified T cell (CAR-T) co-expressed with ICOSL-41BB promote CAR-T proliferation and tumor rejection
- (2019) Wei Hu et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
- (2019) Bettina Langhans et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
- (2019) Qiming Zhang et al. CELL
- REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
- (2019) Tatsuya Yamashita et al. JOURNAL OF GASTROENTEROLOGY
- Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization
- (2019) Guolong Xu et al. ONCOGENE
- Liver-Mediated Adaptive Immune Tolerance
- (2019) Meijuan Zheng et al. Frontiers in Immunology
- Identification of an HLA‐A*24:02‐restricted α ‐fetoprotein signal peptide‐derived antigen and its specific T‐cell receptor for T‐cell immunotherapy
- (2019) Zhenjuan Li et al. IMMUNOLOGY
- Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification
- (2018) Yutaka Kurebayashi et al. HEPATOLOGY
- B lymphocytes limit senescence-driven fibrosis resolution and favor hepatocarcinogenesis in mouse liver injury
- (2018) Francesca Faggioli et al. HEPATOLOGY
- Transforming Growth Factor-β and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma
- (2018) Christine Haider et al. HEPATOLOGY
- Neutrophil extracellular traps promote inflammation and development of hepatocellular carcinoma in nonalcoholic steatohepatitis
- (2018) Dirk J. van der Windt et al. HEPATOLOGY
- Identification of α-fetoprotein-specific T-cell receptors for hepatocellular carcinoma immunotherapy
- (2018) Wei Zhu et al. HEPATOLOGY
- Predominance of regorafenib over sorafenib: Restoration of membrane-bound MICA in hepatocellular carcinoma cells
- (2018) Jun Arai et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
- (2018) Min Yu et al. MOLECULAR THERAPY
- The immunology of hepatocellular carcinoma
- (2018) Marc Ringelhan et al. NATURE IMMUNOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dendritic cells as cancer therapeutics
- (2018) Christian E. Bryant et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma
- (2018) Yusheng Cheng et al. Cell Death & Disease
- Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab
- (2018) Gong Chen et al. Oncotarget
- Effect of dendritic cell–based immunotherapy on hepatocellular carcinoma: A systematic review and meta-analysis
- (2018) CONG CHEN et al. CYTOTHERAPY
- Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma
- (2018) Stefania Mantovani et al. HEPATOLOGY
- CCL15 recruits suppressive monocytes to facilitate immune escape and disease progression in hepatocellular carcinoma
- (2018) Long-Zi Liu et al. HEPATOLOGY
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
- (2018) Pascale André et al. CELL
- Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
- (2018) Fasiha Kanwal et al. GASTROENTEROLOGY
- Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
- (2018) Hyung-Don Kim et al. GASTROENTEROLOGY
- Human CD96 correlates to NK cell exhaustion and predicts the prognosis of human hepatocellular carcinoma
- (2018) Haoyu Sun et al. HEPATOLOGY
- Tuning T cell receptor affinity to optimize clinical risk-benefit when targeting α-fetoprotein-positive liver cancer
- (2018) Roslin Y. Docta et al. HEPATOLOGY
- HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers
- (2018) Hongli Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma
- (2018) Xingliang Guo et al. Frontiers in Pharmacology
- Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
- (2017) Guoying Zhou et al. GASTROENTEROLOGY
- Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
- (2017) Jingying Zhou et al. GUT
- Targeting hepatic macrophages to treat liver diseases
- (2017) Frank Tacke JOURNAL OF HEPATOLOGY
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma
- (2017) Jian-Yang Ao et al. MOLECULAR CANCER THERAPEUTICS
- Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
- (2017) Shabnam Shalapour et al. NATURE
- PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
- (2017) Sydney R. Gordon et al. NATURE
- The gut microbiome and liver cancer: mechanisms and clinical translation
- (2017) Le-Xing Yu et al. Nature Reviews Gastroenterology & Hepatology
- Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers
- (2017) Y Liu et al. ONCOGENE
- Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy
- (2017) Zachary B. Davis et al. SEMINARS IN IMMUNOLOGY
- Zoledronic acid inhibits infiltration of tumor-associated macrophages and angiogenesis following transcatheter arterial chemoembolization in rat hepatocellular carcinoma models
- (2017) Da-Yong Zhou et al. Oncology Letters
- FDA Approves Second CAR T-cell Therapy
- (2017) Cancer Discovery
- Capecitabine Extends Survival for Biliary Tract Cancer
- (2017) Cancer Discovery
- Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer
- (2017) Mao Lin et al. Oncotarget
- Tumor-infiltrating B cells producing antitumor active immunoglobulins in resected HCC prolong patient survival
- (2017) Stefan M. Brunner et al. Oncotarget
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
- (2017) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Human Tumor-Infiltrating Myeloid Cells: Phenotypic and Functional Diversity
- (2017) Louise A. Elliott et al. Frontiers in Immunology
- Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches
- (2017) Min Yu et al. Frontiers of Medicine
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities
- (2017) Nirmala Chandralega Kampan et al. CURRENT MEDICINAL CHEMISTRY
- High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis
- (2016) Qiang-Bo Zhang et al. BMC CANCER
- Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
- (2016) Cheng Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Liver immunology and its role in inflammation and homeostasis
- (2016) Mark W Robinson et al. Cellular & Molecular Immunology
- Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
- (2016) Shao-Lai Zhou et al. GASTROENTEROLOGY
- Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid
- (2016) Yohji Honda et al. HEPATOLOGY RESEARCH
- Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
- (2016) Ghassan K. Abou-Alfa et al. JOURNAL OF HEPATOLOGY
- Change of the peripheral blood immune pattern and its correlation with prognosis in patients with liver cancer treated by sorafenib
- (2016) Chang-Jiang Lei et al. Asian Pacific Journal of Tropical Medicine
- Dendritic cell-elicited B-cell activation fosters immune privilege via IL-10 signals in hepatocellular carcinoma
- (2016) Fang-Zhu Ouyang et al. Nature Communications
- Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
- (2016) Vincenzo Bronte et al. Nature Communications
- PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression
- (2016) X. Xiao et al. Cancer Discovery
- Expanded and Activated Natural Killer Cells for Immunotherapy of Hepatocellular Carcinoma
- (2016) T. Kamiya et al. Cancer Immunology Research
- Hepatocellular carcinoma
- (2016) Josep M. Llovet et al. Nature Reviews Disease Primers
- Association of Biomarker-Based Treatment Strategies With Response Rates and Progression-Free Survival in Refractory Malignant Neoplasms
- (2016) Maria Schwaederle et al. JAMA Oncology
- Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular Carcinoma
- (2016) Hongwei Xue et al. PLoS One
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
- (2015) Jessica Zucman-Rossi et al. GASTROENTEROLOGY
- Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma
- (2015) Xiaoguang Li et al. GUT
- Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
- (2015) Marta Garnelo et al. GUT
- Liver inflammation abrogates immunological tolerance induced by Kupffer cells
- (2015) Felix Heymann et al. HEPATOLOGY
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
- (2015) Gaixia He et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Immunotherapy of HCC metastases with autologous T cell receptor redirected T cells, targeting HBsAg in a liver transplant patient
- (2015) Waseem Qasim et al. JOURNAL OF HEPATOLOGY
- Distribution of HLA haplotypes across Japanese Archipelago: similarity, difference and admixture
- (2015) Hirofumi Nakaoka et al. JOURNAL OF HUMAN GENETICS
- Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
- (2015) Tamás Rőszer MEDIATORS OF INFLAMMATION
- Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
- (2015) Laura J Pallett et al. NATURE MEDICINE
- Inflammasome activation and function in liver disease
- (2015) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance
- (2015) B Ye et al. Cell Death & Disease
- NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
- (2015) Wei Wang Frontiers in Immunology
- Tumor-infiltrating plasmacytoid dendritic cells promote immunosuppression by Tr1 cells in human liver tumors
- (2015) Alexander Pedroza-Gonzalez et al. OncoImmunology
- Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis
- (2014) Wei-Kai Xiao et al. BMC CANCER
- Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway
- (2014) Yan Shao et al. CANCER LETTERS
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis
- (2014) Jean Charles Nault et al. HEPATOLOGY
- Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
- (2014) Takeshi Terashima et al. HEPATOLOGY RESEARCH
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
- (2014) Peter J. Murray et al. IMMUNITY
- Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects
- (2014) Yukai He et al. Immunotherapy
- OK432-Activated Human Dendritic Cells Kill Tumor Cells via CD40/CD40 Ligand Interactions
- (2014) K. S. Hill et al. JOURNAL OF IMMUNOLOGY
- Immune control and failure in HCV infection-tipping the balance
- (2014) Lynn B. Dustin et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
- (2014) Yasushi Totoki et al. NATURE GENETICS
- Identification of serum CCL15 in hepatocellular carcinoma
- (2013) Y Li et al. BRITISH JOURNAL OF CANCER
- Non-Cell-Autonomous Tumor Suppression by p53
- (2013) Amaia Lujambio et al. CELL
- Margin-Infiltrating CD20+ B Cells Display an Atypical Memory Phenotype and Correlate with Favorable Prognosis in Hepatocellular Carcinoma
- (2013) J.-Y. Shi et al. CLINICAL CANCER RESEARCH
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
- (2013) Martin Franz Sprinzl et al. HEPATOLOGY
- Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
- (2013) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
- (2013) Bastian Höchst et al. JOURNAL OF HEPATOLOGY
- Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
- (2013) Shin Yoshimoto et al. NATURE
- Immune surveillance by the liver
- (2013) Craig N Jenne et al. NATURE IMMUNOLOGY
- The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
- (2013) Ling-Qun Kong et al. PLoS One
- High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
- (2013) Jean Charles Nault et al. Nature Communications
- Regulatory dendritic cells program B cells to differentiate into CD19hiFc IIbhi regulatory B cells through IFN- and CD40L
- (2012) L. Qian et al. BLOOD
- Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer
- (2012) Carlo Schneider et al. GUT
- Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma
- (2012) Shao-Lai Zhou et al. HEPATOLOGY
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
- (2012) Eishiro Mizukoshi et al. HEPATOLOGY
- Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions
- (2012) Yan Wu et al. HEPATOLOGY
- Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma
- (2012) Cécile Guichard et al. NATURE GENETICS
- B regulatory cells in cancer
- (2012) Frances Balkwill et al. TRENDS IN IMMUNOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells
- (2011) Timea Csak et al. HEPATOLOGY
- Chemokines: A New Dendritic Cell Signal for T Cell Activation
- (2011) Christoph A. Thaiss et al. Frontiers in Immunology
- Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization
- (2010) Y. Nakamoto et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Population-based risk factors and resource utilization for HCC: US perspective
- (2010) A. Sanyal et al. CURRENT MEDICAL RESEARCH AND OPINION
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
- (2010) Feng Shi et al. INTERNATIONAL JOURNAL OF CANCER
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
- (2010) Dong-Ming Kuang et al. JOURNAL OF HEPATOLOGY
- Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
- (2009) Bastian Hoechst et al. HEPATOLOGY
- Chronically inflamed livers up-regulate expression of inhibitory B7 family members
- (2009) Rachel Kassel et al. HEPATOLOGY
- Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1
- (2009) Dong-Ming Kuang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
- (2009) Valerie Chew et al. JOURNAL OF HEPATOLOGY
- Liver tumor infiltrating lymphocytes: Comparison of hepatocellular and cholangiolar carcinoma
- (2009) Hans-Udo Kasper et al. WORLD JOURNAL OF GASTROENTEROLOGY
- EpCAM and -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
- (2008) T. Yamashita et al. CANCER RESEARCH
- Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
- (2008) Lun Cai et al. CLINICAL IMMUNOLOGY
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T Cells
- (2008) Bastian Hoechst et al. GASTROENTEROLOGY
- Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
- (2008) G Ahlen et al. GUT
- A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
- (2008) Daniel H. Palmer et al. HEPATOLOGY
- Comprehensive analysis of the α-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma
- (2008) Robert Thimme et al. HEPATOLOGY
- High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection
- (2008) Tong Ding et al. HUMAN PATHOLOGY
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
- (2008) Xiao-Dong Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection
- (2008) Abhishek Das et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation